Skip to content

Clinical trials

Glomerulonephritis trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulonephritis Country / region: China Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20101
20121
20141
20161
20201
20212
20224
20234
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Unknown status5
Active, not recruiting4
Recruiting4
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
argenx2
Alpine Immune Sciences Inc, A Subsidiary of Vertex1
Chen Dajin1
Chengdu Suncadia Medicine Co., Ltd.1
Chinese PLA General Hospital1
George (Beijing) Clinical Research Co. Ltd.1
Guangdong Provincial People's Hospital1
Human Genome Sciences Inc., a GSK Company1
Peking Union Medical College Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulonephritis21
Kidney Diseases11
Glomerulonephritis, IGA10
Renal Insufficiency, Chronic6
Urologic Diseases6
Nephritis4
Autoimmune Diseases3
Lupus Nephritis3
Glomerulonephritis, Membranous2
Diabetic Nephropathies1

Trials

Showing 51 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.